Modex Therapeutics
ModeX Therapeutics, an OPKO Health company, is the leading clinical-stage biopharmaceutical company developing unique and proprietary multispecific therapeutics. Its MSTAR platform unites the power of multiple biologics in a single molecule to create multispecific antibodies that bind four or more targets with unprecedented versatility and potency for complex diseases. Its promising first-in-class immunology pipeline includes candidates against immune diseases, including cancer (both solid and hematologic tumors), immune impairment, as well as several of the world’s most pressing viral threats. Our founding team includes globally recognized medical innovators with proven track records of delivering breakthroughs for patients.
-
Elias ZerhouniModeX Therapeutics, Co-Founder
Opko Health, President and Vice Chairman of the Board of Directors -
Gary NabelModeX Therapeutics, Co-Founder, President and CEO
Opko Health, Chief Innovation Officer and Board Director -
John MascolaChief Scientific Officer -
Giovanni AbbadessaChief Medical Officer -
Kerry CulmChief Development Officer -
Ji ZhangChief Operating Officer
We believe that the true measure of an innovation’s impact is the number of patients it helps. A drive to work on the most complex scientific challenges of our time is necessary but not sufficient by itself—creative thinking is what will separate us from everyone else. We are a project-focused group committed to fostering a culture where a wide variety of perspectives are valued. We’re ambitious, but we have fun working together and know the best science is a product of creative collaboration.
We are shaping a new and better way to make transformational medicines a reality for people in need.
-
“It’s the people within ModeX that make it special. The leadership team is second to none in terms of scientific accolades and business acumen -that’s why I joined, because I knew we have a real chance to make breakthrough therapies here. We have terrific scientists that are all working to make ModeX a potential shooting star in the medical world.”
Ed Seung, Principal Scientist -
“ModeX - from senior leaders to young bench scientists - has fostered a collaborative and science-first working culture that really motivates and challenges us to do our best every day.”
Hao Chen, Director, Protein Sciences -
“My position at ModeX is my first job after receiving my doctorate, and I could not have asked for a better experience. The location, the people, and the science each speaks for itself. It’s a privilege and a career-defining opportunity to be on such an ambitious and sophisticated team rapidly advancing promising therapies towards the clinic.”
Mark Greci, Scientist
